-
公开(公告)号：US09732143B2
公开(公告)日：2017-08-15
申请号：US13982669
申请日：2012-02-03
IPC分类号： C07K16/00 , C07K14/245 , C12N9/90 , C12N15/67 , C07K14/005
CPC分类号： C07K16/00 , C07K14/005 , C07K14/245 , C07K2319/00 , C07K2319/35 , C12N9/90 , C12N15/67 , C12Y502/01008
摘要： Novel materials and methods useful for expressing heterologous proteins in prokaryotic cells are provided, including prokaryotic cells expressing FkpA and/or Skp.
-
公开(公告)号：US07595174B2
公开(公告)日：2009-09-29
申请号：US11550194
申请日：2006-10-17
申请人： Lowell J. Brady , Kevin M. Klucher , Chung-leung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung-leung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
摘要翻译： 已经通过在编码成熟蛋白的多核苷酸序列中突变一个或多个半胱氨酸残基来产生IL-28A，IL-28B和IL-29的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。 所示的一种生物活性是抗病毒活性。
-
公开(公告)号：US07468423B2
公开(公告)日：2008-12-23
申请号：US11549469
申请日：2006-10-13
申请人： Lowell J. Brady , Kevin M. Klucher , Chung-leung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung-leung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
摘要翻译： 已经通过在编码成熟蛋白的多核苷酸序列中突变一个或多个半胱氨酸残基来产生IL-28A，IL-28B和IL-29的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。 所示的一种生物活性是抗病毒活性。
-
公开(公告)号：US20130149279A1
公开(公告)日：2013-06-13
申请号：US13094959
申请日：2011-04-27
IPC分类号： C07K14/54
CPC分类号： C07K14/54 , A61K38/00 , A61K38/20 , Y02A50/473
摘要： Homogeneous preparations of human and murine IL-31 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity.
-
公开(公告)号：US20100297065A1
公开(公告)日：2010-11-25
申请号：US12478185
申请日：2009-06-04
CPC分类号： C07K14/54 , A61K38/00 , A61K38/20 , Y02A50/473
摘要： Homogeneous preparations of human and murine IL-31 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity.
摘要翻译： 已经通过在编码成熟蛋白质的多核苷酸序列中突变一个或多个半胱氨酸残基来产生人和鼠IL-31的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。
-
公开(公告)号：US07858341B2
公开(公告)日：2010-12-28
申请号：US11301383
申请日：2005-12-12
CPC分类号： C07K14/501 , C07K14/50
摘要： The expression vectors and methods using an E. coli expression system for the large scale production of FGF18 are described. The vectors utilize the FGF18 coding sequence with specific changes in nucleotides in order to optimize codons and mRNA secondary structure for translation in E. coli. Using the expression vectors, the FGF18 gene was produced in E. coli to a level of greater than 1 g/L in fed batch fermentation. Also included are OmpT deficient E. coli strains, as well as OmpT and fhuA negative strains transformed with an FGF18 expression vector.
摘要翻译： 描述了使用用于大规模生产FGF18的大肠杆菌表达系统的表达载体和方法。 载体利用具有核苷酸特异性变化的FGF18编码序列，以优化用于大肠杆菌翻译的密码子和mRNA二级结构。 使用表达载体，在补料分批发酵中，大肠杆菌中产生FGF18基因至大于1g / L的水平。 还包括OmpT缺陷型大肠杆菌菌株，以及用FGF18表达载体转化的OmpT和fhuA阴性菌株。
-
公开(公告)号：US07544779B2
公开(公告)日：2009-06-09
申请号：US11549531
申请日：2006-10-13
申请人： Lowell J. Brady , Kevin M. Klucher , Chung-leung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung-leung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
摘要翻译： 已经通过在编码成熟蛋白的多核苷酸序列中突变一个或多个半胱氨酸残基来产生IL-28A，IL-28B和IL-29的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。 所示的一种生物活性是抗病毒活性。
-
8.发明申请METHODS AND MATERIALS FOR ENHANCING FUNCTIONAL PROTEIN EXPRESSION IN BACTERIA 有权用于增强细菌中功能蛋白表达的方法和材料公开(公告)号：US20140154743A1
公开(公告)日：2014-06-05
申请号：US13982669
申请日：2012-02-03
IPC分类号： C07K16/00 , C07K14/005
CPC分类号： C07K16/00 , C07K14/005 , C07K14/245 , C07K2319/00 , C07K2319/35 , C12N9/90 , C12N15/67 , C12Y502/01008
摘要： Novel materials and methods useful for expressing heterologous proteins in prokaryotic cells are provided, including prokaryotic cells expressing FkpA and/or Skp.
摘要翻译： 提供了用于在原核细胞中表达异源蛋白质的新型材料和方法，包括表达FkpA和/或Skp的原核细胞。
-
公开(公告)号：US20060228329A1
公开(公告)日：2006-10-12
申请号：US11344451
申请日：2006-01-30
申请人： Lowell Brady , Thomas Bukowski , Chung-leung Chan
发明人： Lowell Brady , Thomas Bukowski , Chung-leung Chan
CPC分类号： C07K14/54 , A61K38/00 , A61K38/20 , Y02A50/473
摘要： Homogeneous preparations of human and murine IL-31 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity.
摘要翻译： 已经通过在编码成熟蛋白质的多核苷酸序列中突变一个或多个半胱氨酸残基来产生人和鼠IL-31的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.02 秒)
